Browsing by Ajou Author

researcher image
김, 대중(Kim, Dae Jung) Currently indexed / E-mail
[School of Medicine / Graduate School of Medicine] - [Endocrinology & Metabolism]

Showing results 51 to 100 of 316

This table browses all dspace content
Pub YearTitle & CitationAJOU Author(s)
2022Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway
Biomedicines, 10(5). : 1032-1032, 2022
강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2022Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
The lancet. Diabetes & endocrinology, 10(11). : 795-803, 2022
김대중, 하경화
2022Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
The lancet. Diabetes & endocrinology, 10(2). : 112-119, 2022
김대중, 하경화
2022Reply to “Recommendation on an updated standardization of serum magnesium reference ranges,” Jeroen H.F. de Baaij et al.
European journal of nutrition, 61(8). : 4235-4237, 2022
김대중
2022Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study
International journal of environmental research and public health, 19(5). : 2823-2823, 2022
김대중, 김은진, 정윤정, 최영화, 하경화, 허중연
2022Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Cancer: A Population-Based Cohort Study Using a Common Data Model
Diagnostics (Basel, Switzerland), 12(2). : 263-263, 2022
김대중, 박래웅
2022Association Between Social Network and Cognitive Function: A Cross-Sectional Assessment From the Cardiovascular and Metabolic Diseases Etiology Research Center Cohort (2013–2018)
Frontiers in psychiatry, 13. : 893290-893290, 2022
김대중
2022The Degree of Glycemic Control for the First Three Months Determines the Next Seven Years
Journal of Korean medical science, 37(38). : e301-e301, 2022
김대중, 이나미
2022Recommendation on an updated standardization of serum magnesium reference ranges
European journal of nutrition, 61(7). : 3697-3706, 2022
김대중
2022Associations between non-alcoholic fatty liver disease and cognitive impairment and the effect modification of inflammation
Scientific reports, 12(1). : 12614-12614, 2022
김대중
2022Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study
Journal of diabetes investigation, 13(6). : 986-996, 2022
김대중, 최용준, 하경화
2022Cardiovascular disease in patients with type 2 diabetes
Journal of diabetes investigation, 13(4). : 614-616, 2022
김대중, 전자영
2022Healthcare resource utilization in patients treated with empagliflozin in East Asia
Journal of diabetes investigation, 13(5). : 810-821, 2022
김대중, 하경화
2022Prevalence and clinical characteristics of fulminant type 1 diabetes mellitus in Korean adults: A multi-institutional joint research
Journal of diabetes investigation, 13(1). : 47-53, 2022
김대중, 전자영
20212021 clinical practice guidelines for diabetes mellitus in Korea
Diabetes & metabolism journal, 45(4). : 461-481, 2021
김대중
2021Status of diabetic neuropathy in Korea: A national health insurance service-national sample cohort analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9)
Diabetes & metabolism journal, 45(3). : 459-460, 2021
김대중
2021Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
Cardiovascular diabetology, 20(1). : 159-159, 2021
김대중
2021Acute glucose shift induces the activation of the nlrp3 inflammasome in thp-1 cells
International journal of molecular sciences, 22(18). : 9952-9952, 2021
강엽, 김대중, 김혜진, 이관우, 한승진
2021Association between social network structure and physical activity in middle-aged Korean adults
Social science & medicine (1982), 282. : 114112-114112, 2021
김대중
2021Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF- κ B, MKK7/JNK, and JAK2/STAT1 Signalling Pathways
Journal of immunology research, 2021. : 9944880-9944880, 2021
강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2021Erratum: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea
Diabetes & metabolism journal, 45(2). : 283-283, 2021
김대중, 하경화
2021Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19
Diabetes & metabolism journal, 45(2). : 251-259, 2021
김대중
2021Effect of teneligliptin versus sulfonylurea on major adverse cardiovascular outcomes in people with type 2 diabetes mellitus: A real-world study in Korea
Endocrinology and metabolism (Seoul, Korea), 36(1). : 70-80, 2021
김대중, 하경화
2021Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings
The lancet. Diabetes & endocrinology, 9(4). : 203-211, 2021
김대중, 하경화
2021Temporal change in the diagnosis and treatment rates of osteoporosis: results from the Korea National Health and Nutrition Examination Survey
Osteoporosis international, 32(9). : 1777-1784, 2021
김대중, 박범희, 정윤석, 최용준
2021Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model
Journal of gastroenterology and hepatology, 36(9). : 2592-2600, 2021
강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2021Status of diabetic neuropathy in Korea: A national health insurance service-national sample cohort analysis (2006 to 2015)
Diabetes & metabolism journal, 45(1). : 115-119, 2021
김대중
2021Trends in cardiovascular complications and mortality among patients with diabetes in South Korea
Diabetes & metabolism journal, 45(1). : 120-124, 2021
김대중, 하경화
2021Cardiovascular safety of sodium glucose cotransporter 2 inhibitors as add-on to metformin monotherapy in patients with type 2 diabetes mellitus
Diabetes & metabolism journal, 45(4). : 505-514, 2021
김대중, 전자영, 하경화
2021Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study
Diabetes, obesity & metabolism, 23(3). : 682-691, 2021
김대중, 이나미, 하경화, 한승진
2021Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
Diabetes, obesity & metabolism, 23(1). : 75-85, 2021
김대중, 하경화
2020Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
Endocrinology, diabetes & metabolism, 4(1). : e00183-e00183, 2020
김대중, 하경화
2020Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea
Diabetes & metabolism journal, 44(6). : 933-937, 2020
김대중, 박인휘, 이민정, 하경화
2020Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea
Endocrinology and metabolism (Seoul, Korea), 35(4). : 901-908, 2020
김대중
2020Association of social network size and composition with physical activity in Korean middle-aged adults
Epidemiology and health, 42. : e2020070-e2020070, 2020
김대중
2020Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study
Cardiovascular diabetology, 19(1). : 191-191, 2020
김대중, 하경화
2020Associations between social network properties and metabolic syndrome and the mediating effect of physical activity: findings from the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort
BMJ open diabetes research & care, 8(1). : e001272-e001272, 2020
김대중
2020Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis
Diabetes & metabolism journal, 44(6). : 928-932, 2020
김대중, 이기황, 정유리, 하경화
2020Obesity Fact Sheet in Korea, 2019: Prevalence of Obesity and Abdominal Obesity from 2009 to 2018 and Social Factors
Journal of obesity & metabolic syndrome, 29(2). : 124-132, 2020
김대중, 이관우
2020Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study
Cardiovascular diabetology, 19(1). : 67-67, 2020
김대중
2020Effects of cigarette smoking on blood lipids in Korean men: Cardiovascular and Metabolic Diseases Etiology Research Center cohort
The Korean journal of internal medicine, 35(2). : 369-382, 2020
김대중
2020Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study
Diabetes & metabolism journal, 44(1). : 125-133, 2020
김대중, 김혜진, 문소영, 이관우, 전자영, 한승진
2020Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study
The lancet. Diabetes & endocrinology, 8(7). : 606-615, 2020
김대중
2020CCL20 induced by visfatin in macrophages via the NF-kappaB and MKK3/6-p38 signaling pathways contributes to hepatic stellate cell activation
Molecular biology reports, 47(6). : 4285-4293, 2020
강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진
2019Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
Cancer management and research, 11. : 7427-7438, 2019
김대중
2019Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis
Diabetes, metabolic syndrome and obesity : targets and therapy, 12. : 1161-1171, 2019
김대중, 전자영
2019Circulating calcium levels and the risk of type 2 diabetes: a systematic review and meta-analysis
The British journal of nutrition, 122(4). : 376-387, 2019
김대중
2019Visfatin Induces Inflammation and Insulin Resistance via the NF-kappaB and STAT3 Signaling Pathways in Hepatocytes
Journal of diabetes research, 2019. : 4021623-4021623, 2019
강엽, 김대중, 김혜진, 이관우, 전자영, 최성이, 한승진
2019Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640-8)
Diabetes & metabolism journal, 43(6). : 917-918, 2019
김대중, 이기황, 정유리, 하경화
20192019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
Diabetes & metabolism journal, 43(4). : 398-406, 2019
김대중
1 2 3 4 5 6 7

Browse